Intestinal Tuberculosis Presenting with Diarrhea: Evaluation and Treatment
Treatment Recommendation
Treat intestinal tuberculosis with the standard 6-month regimen: isoniazid, rifampin, pyrazinamide, and ethambutol daily for 2 months, followed by isoniazid and rifampin daily for 4 months. 1, 2
This recommendation is based on high-quality guideline evidence demonstrating that 6-month therapy is as effective as 9-month therapy for intestinal TB, with the added benefits of reduced cost and improved compliance 3.
Initial Evaluation Strategy
Clinical Assessment
- Suspect intestinal TB in patients presenting with:
Critical Diagnostic Pitfall
- 85% of intestinal TB patients have no pulmonary involvement, so normal chest imaging does not exclude the diagnosis 1, 2
- The ileocecal region and terminal ileum are involved in 50-90% of cases, making this the most critical area to evaluate 1, 2
Diagnostic Workup
- CT abdomen with contrast is the imaging modality of choice 2
- Colonoscopy with multiple biopsies from the ileocecal region confirms diagnosis in 77% of cases 2, 4
- Histopathology showing granulomas, caseous necrosis, or histiocytic ulcers has 69-97% sensitivity 2
- Microbiological examination (culture and drug sensitivity testing) should be performed despite low sensitivity in paucibacillary disease 2
Differential Diagnosis: Distinguishing from Crohn's Disease
This distinction is life-threatening because treating TB as Crohn's disease with immunosuppression can cause fulminant TB progression and death 2.
Features Favoring Tuberculosis
- Transverse ulcers, patulous ileocecal valve, and pseudopolyps on colonoscopy 2
- Positive tuberculin skin test and night sweats 2
- Epidemiological factors: immigration from endemic areas, HIV/AIDS, recent immunosuppression 2
When Diagnosis Remains Uncertain
- Consider therapeutic trial with anti-tubercular therapy in endemic areas, monitoring for early mucosal response and resolution of symptoms 2
- Never initiate immunosuppression without excluding TB first, especially in immunocompromised patients 1-6 months post-transplant when risk is maximal 2
Treatment Protocol
Standard 6-Month Regimen
- Intensive phase (2 months): Isoniazid, rifampin, pyrazinamide, and ethambutol administered daily 1, 2
- Continuation phase (4 months): Isoniazid and rifampin administered daily 1, 2
When to Extend Treatment Beyond 6 Months
- HIV-positive patients: Extend to at least 9 months 1
- Culture-positive patients at completion of initial therapy 2
- Resistant organisms identified 2
Avoid Intermittent Dosing
- Never use once-weekly therapy with isoniazid and rifapentine in the continuation phase 5
- If intermittent therapy is necessary, use thrice-weekly instead of twice-weekly to allow for missed doses 5
Managing Gastrointestinal Side Effects
Common GI Reactions from Anti-TB Drugs
- Epigastric distress and nausea are common early in therapy 5
- Take medications at bedtime to minimize symptoms 5
- Use antacids rather than food, as they have less impact on drug absorption 5
When to Suspect Drug-Induced Hepatotoxicity
- Any combination of unexplained nausea, vomiting, and abdominal pain requires immediate evaluation 5
- Check liver function tests (ALT, AST, bilirubin, alkaline phosphatase) 5
- Stop all hepatotoxic TB drugs immediately if ALT ≥5× upper limit of normal without symptoms, or ≥3× upper limit of normal with hepatitis symptoms 5, 6
Drug Reintroduction After Hepatotoxicity
- Wait until liver enzymes return to <2× upper limit of normal and symptoms resolve 6
- Reintroduce drugs sequentially with daily monitoring: start isoniazid 50 mg/day, increase to 300 mg/day after 2-3 days, then add rifampin 75 mg/day after 2-3 additional days 6
- If pyrazinamide caused severe hepatotoxicity, do not reintroduce it; use isoniazid, rifampin, and ethambutol for 2 months, then isoniazid and rifampin for 7 months 6
Surgical Indications
Surgery is reserved for specific complications 1, 2:
- Intestinal perforation (resection and anastomosis preferred) 1
- Obstruction not responding to medical therapy 2
- Diagnostic uncertainty requiring tissue diagnosis 2
- Fistula formation 2
Critical Pitfalls to Avoid
- Do not dismiss TB based on negative chest imaging—85% have no pulmonary involvement 1, 2
- Do not start immunosuppression without excluding TB first—this can be fatal 2
- Do not use once-weekly continuation therapy—high relapse rates and resistance 5
- Do not ignore hepatitis symptoms—stop hepatotoxic drugs immediately and evaluate 5, 6
- Median time to diagnosis is 13 weeks—maintain high clinical suspicion to avoid delays 4